<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL
INFORMATION EXTRACTED FROM THE MEDISYS
TECHNOLOGIES, INC. FINANCIAL STATEMENTS FOR THE
PERIOD ENDED MARCH 31, 2000 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
<MULTIPLIER> 1
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> MAR-31-2000
<CASH> 1,315,550
<SECURITIES> 0
<RECEIVABLES> 340
<ALLOWANCES> 0
<INVENTORY> 7,729
<CURRENT-ASSETS> 1,347,447
<PP&E> 20,112
<DEPRECIATION> 0
<TOTAL-ASSETS> 1,870,228
<CURRENT-LIABILITIES> 1,938,043
<BONDS> 1,000,000
0
0
<COMMON> 29,502
<OTHER-SE> 15,825,362
<TOTAL-LIABILITY-AND-EQUITY> 1,870,228
<SALES> 623
<TOTAL-REVENUES> 623
<CGS> 679
<TOTAL-COSTS> 3,012,563
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 162,000
<INCOME-PRETAX> (3,167,395)
<INCOME-TAX> 0
<INCOME-CONTINUING> (3,167,395)
<DISCONTINUED> (1,379,954)
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (4,547,349)
<EPS-BASIC> (.09)
<EPS-DILUTED> (.09)
</TABLE>